Page last updated: 2024-09-04

moxifloxacin and Sinusitis, Maxillary

moxifloxacin has been researched along with Sinusitis, Maxillary in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's6 (85.71)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adelglass, J; Benson, A; Johnson, P; Keating, K; Pertel, P; Rankin, B; Sterling, R1
Franco Hidalgo, S; GarcĂ­a Lorenzo, R; Prieto de Paula, JM; Salado Valdivieso, I1
Egorov, VI; Kozarenko, AV1
Arvis, P; Klossek, JM; Leberre, MA; Nikolaidis, P; Siegert, R1
Chuchueva, NG; Ivanchenko, OA; Lopatin, AS1
Burke, T; Church, D; Haverstock, D; Heyd, A; Huck, W; Mariano, H; Orchard, D; Villanueva, C1
Flores, SM; Heyd, A; Rakkar, S; Roberts, K; Towe, BF; Warner, J1

Trials

4 trial(s) available for moxifloxacin and Sinusitis, Maxillary

ArticleYear
Acute bacterial maxillary sinusitis: time to symptom resolution and return to normal activities with moxifloxacin.
    International journal of clinical practice, 2008, Volume: 62, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Treatment Outcome; Young Adult

2008
Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
    The Journal of laryngology and otology, 2003, Volume: 117, Issue:1

    Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Naphthyridines; Prospective Studies; Quinolines; Treatment Outcome

2003
Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Sinusitis Infection Study Group.
    Clinical therapeutics, 1999, Volume: 21, Issue:10

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Cefuroxime; Cephalosporins; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines

1999
Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience.
    International journal of clinical practice, 2001, Volume: 55, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Treatment Outcome

2001

Other Studies

3 other study(ies) available for moxifloxacin and Sinusitis, Maxillary

ArticleYear
[Moxifloxacin and hepatic toxicity].
    Gastroenterologia y hepatologia, 2009, Volume: 32, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Moxifloxacin; Quinolines

2009
[Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis].
    Vestnik otorinolaringologii, 2002, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Frontal Sinusitis; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Quinolines; Sinusitis; Suppuration; Time Factors

2002
[Avelox efficacy in the treatment of acute purulent rhinosinusitis].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:8

    Topics: Acute Disease; Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Moxifloxacin; Quinolines; Rhinitis; Suppuration; Tomography, X-Ray Computed; Treatment Outcome

2007